PORGAVIXIMAB

UNII:	07EY0HWO2M
Formula:
Preferred Substance Name:	PORGAVIXIMAB
GSRS Full Record:	07EY0HWO2M i

1792982-55-8
2G4
C2G4
IMMUNOGLOBULIN G1, ANTI-(EBOLAVIRUS GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL C2G4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C2G4 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(EBOLAVIRUS GLYCOPROTEIN) CHIMERIC HOMO SAPIENS-MUS MUSCULUS MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-451) (MUS MUSCULUS VH (IGHV6-6*02 (95%) (IGHD)-IGHJ4*01 (94%)) (8.10.12) (1-121) -HOMO SAPIENS IGHG1*01(CH1 K97>R(218)) (122-451)) (224-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (MUS MUSCULUS V-KAPPA (IGKV12-46*01 (95%) IGKJ2*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')) DIMER (230-230'':233-233'')-BISDISULFIDE
PORGAVIXIMAB [INN]
PORGAVIXIMAB [USAN]
PORGAVIXIMAB [WHO-DD]
ZMAP COMPONENT C2G4
ZMAPP COMPONENT C2G4

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PORGAVIXIMAB

Synonyms and Mappings

Resources